Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 6Breast 6Genitourinary 5Thoracic 3Dermatologic 2Plasma cell 1Other neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Prostatic Neoplasms 2966Carcinoma, Renal Cell 882Urinary Bladder Neoplasms 711Kidney Neoplasms 457Breast Neoplasms 408Neoplasms 390Neoplasm Metastasis 229Carcinoma, Non-Small-Cell Lung 229Lung Neoplasms 216Ovarian Neoplasms 211Colorectal Neoplasms 204Melanoma 195Carcinoma, Transitional Cell 190Testicular Neoplasms 171Pancreatic Neoplasms 142Sarcoma 129Head and Neck Neoplasms 121Colonic Neoplasms 120Wilms Tumor 119Uterine Cervical Neoplasms 116Stomach Neoplasms 98Neuroblastoma 90Multiple Myeloma 88Lymphoma, Non-Hodgkin 86Esophageal Neoplasms 86Lymphoma 83Carcinoma, Hepatocellular 81Carcinoma, Ovarian Epithelial 80Recurrence 75Squamous Cell Carcinoma of Head and Neck 74

Interventions

pazopanib 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Patient Preference × Genitourinary × Clear all
NCT05970471 2025-12-12

IMPLICATION

Centre Hospitalier Universitaire de Besancon

Completed
167 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Patient Preference

NCT04936243 2022-12-20

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Dana-Farber Cancer Institute

Phase NA Completed
30 enrolled
BreastGenitourinary

Breast Neoplasms, Patient Participation, Prostatic Neoplasms, Patient Satisfaction, Patient Preference

NCT02032550 2020-08-04

Treatment Preference and Patient Centered Prostate Cancer Care

University of Pennsylvania

Phase NA Completed
743 enrolled 11 charts
Genitourinary

Prostatic Neoplasms, Patient Preference

NCT00595218 2017-07-25

Patient Preference Survey for Radiation Oncologists

University of Pittsburgh

Phase NA Completed
500 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Patient Satisfaction, Patient Preference

NCT01064310 2017-04-17

PISCES

Novartis

Phase 3 Completed
169 enrolled 16 charts
Genitourinary

Carcinoma, Renal Cell, Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡